Breach Cytokine and Humoral Adaptive Immunity and their Correction in Patients with Chronic Osteomyelitis of the Foot Bones

Cite item


Relevance Treatment of chronic osteomyelitis is one of the urgent problems of surgery. Against the background of introduction of new methods of surgical treatment and programs combined antibacterial therapy percentage disability of patients with chronic osteomyelitis remains high. Found that immune mechanisms play an important role in the pathogenesis of chronic osteomyelitis, participating in the formation of the state of the patient secondary immunodeficiency one level or another. The purpose of the study To estimate the effectiveness of treatment of patients with chronic osteomyelitis of foot bones with the use of standard therapy and immunomodulatory drugs (glutoxim or polyoxidonium). Materials and methods Adaptive immunity of 60 patients with chronic osteomyelitis of foot bones, ages of 30-59, admitted to the Department of purulent surgical infection before and after treatment was evaluated. Concentrations of cytokines and immunoglobulins levels were measured by ELISA using commercial kits "Vector-Best". Results and their discussion In patients with chronic osteomyelitis of foot bones marked increase in the level of pro- and antiinflammatory cytokines and reduced blood IgA. Use glutoxim led to effective control of cytokine status, increased levels of IgA. Use of polyoxidonium or glutoxim reduced the number of complete amputation of toes with resection of the metatarsal bone. Conclusion The need to include in the treatment algorithm glutoxim or polyoxidonium. Addition to standard treatment drugs glutoxim and polyoxidonium reduces the amount of disarticulation of toes with resection of the metatarsal

About the authors

Kursk State Medical University, Kursk, Russian Federation

Author for correspondence.
graduate student of surgical diseases FPO Kursk State Medical University, a surgeon general surgery department BMU Kursk Regional Hospital

Kursk State Medical University, Kursk, Russian Federation

MD, PhD, head of the department of microbiology, virology, immunology, Kursk State Medical University, Vice-Rector of KSMU

Kursk State Medical University, Kursk, Russian Federation

MD, PhD, head of the department of Surgical Diseases FPO, Rector of Kursk State Medical University


  1. Amiraslanov Iu.A. Sovremennye principy hirurgicheskogo lecheniya
  2. hronicheskogo osteomielita [Modern principles of surgical treatment
  3. of chronic osteomyelitis]. Infektsii v khirurgii, 2004; 2: 1:
  4. -13. – (In Russian).
  5. Belokhvostikova Iu.S., Leonova S.N., Vinnik Iu.S. Immunnaya korrekciya hronicheskih form ranevoj infekcii [The immune correction of chronic forms of wound infection].
  6. Meditsinskaia immunologiia, 2006; 8: 429-430. – (In
  7. Russian).
  8. Glants S. Mediko-biologicheskaia statistika. [Medical and
  9. biological statistics]. Per. s angl. Moscow, Praktika, 1998;
  10. – (In Russian).
  11. Karaulov A.V., Likov V.F., Evsegneeva I.V., Kokushkov D.V. Ocenka razlichnyh metodov immunomonitoringe
  12. vo vremya immunokorrekcii
  13. [The assessment of different methods of immunomonitoring
  14. during the immunocorrection]. Allergologiia i immunologiia,
  15. ; 6: 2: 136-137. – (In Russian).
  16. Korzhenevskii A.A. Obosnovanie vybora preparata
  17. dlya immunoterapii hronicheskogo osteomielita [ Justification of the choice of the drug
  18. for immunotherapy of chronic osteomyelitis]. Allergologiia
  19. i immunologiia, 2008; 9: 2: 227-230. – (In Russian).
  20. Sepiashvili R.I. Differencirovannaya immunoterapiya
  21. vo vremya hirurgicheskih zabolevanij gnojno-vospalitel'nyh
  22. [ The Differentiated immunotherapy
  23. during surgical pyoinflammatory diseases]. Allergologiia i
  24. immunologiia, 2009; 10: 1: 5-16. – (In Russian).
  25. Cierny G., Doreen D. Lechenie hronicheskoj infekcii [Treatment of chronic infection].
  26. Journal of the American academy of orthopaedic surgeons,
  27. ; 14: 10: 105-110.

Copyright (c) 2013 ., ., .

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies